Ten Capital Wealth Advisors, LLC Astrazeneca PLC Transaction History

Ten Capital Wealth Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$63.15 - $71.6 $24,502 - $27,780	388 Added 119.75%	712 $49,000
Q4 2022 Feb 09, 2023	SELL	$54.21 - $70.44 $1,246 - $1,620	-23 Reduced 6.63%	324 $21,000
Q3 2022 Nov 09, 2022	BUY	$53.02 - $135.75 $1,113 - $2,850	21 Added 6.44%	347 $19,000
Q1 2022 May 09, 2022	SELL	$55.72 - $67.12 $13,372 - $16,108	-240 Reduced 42.4%	326 $22,000
Q2 2021 Aug 12, 2021	BUY	$48.42 - $60.18 $14,526 - $18,054	300 Added 112.78%	566 $34,000
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $12,906 - $15,433	266 New	266 $13,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Ten Capital Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ten Capital Wealth Advisors, LLC with notifications on news.